secwatch.observer — SEC 8-K summary
======================================

Issuer:     GT Biopharma, Inc. (GTBP)
CIK:        0000109657
Form:       8-K
Filed at:   2025-09-26T23:59:59+00:00
Accession:  0001493152-25-015725
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GT Biopharma Series L Preferred holders waive redemption rights – all holders now in agreement
--------------------------------------------------------------------------------

- All Series L 10% Convertible Preferred Stock holders have waived redemption rights under Section 10 of the Certificate of Designations.
- Additional holder provided waiver on September 25, 2025, completing the agreement across all holders.
- Waiver eliminates potential redemption trigger that could require cash outlay, improving liquidity.
- No financial impact disclosed; modification alters preferred stockholder rights.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/109657/000149315225015725/0001493152-25-015725-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/109657/000149315225015725/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-015725

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer